Cerence: A Strong Quarter Can't Mask A Lackluster Growth Story

  • I rate Cerence a 'Hold' for long-term investors due to inconsistent growth and an elevated valuation despite a strong recent quarter. Q2 2025 results exceeded guidance, but management expects no further material fixed license revenue this fiscal year, limiting near-term upside. The lawsuit against Microsoft demonstrates Cerence's commitment to IP protection, but poses significant risks given Microsoft's resources.